When patients with VAP developed adult respiratory distress syndrome (ARDS), their plasma MCP-1 concentrations were significantly higher than those of patients who did not develop ARDS (p = 0.04). This evidence concerns the gene CCL2 and adult acute respiratory distress syndrome.